TP53 and cancer: Wild type p53 status is very clearly associated with a positive clinical outcome and to susceptibility to chemoimmunotherapy in patients with chronic lymphocytic leukaemia (Malcikova et al., 2018) but this positive association is less clear in other cancer types.